“Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program”. SKIN The Journal of Cutaneous Medicine 9, no. 4 (July 23, 2025): s583. Accessed November 16, 2025. https://skin.dermsquared.com/skin/article/view/3493.